{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:51Z","timestamp":1707525171071},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,10]]},"DOI":"10.7759\/cureus.43276","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:14:27Z","timestamp":1691680467000},"source":"Crossref","is-referenced-by-count":0,"title":["Rare Manifestation of Pancreaticobiliary Cancer With Extrahepatic Lesions"],"prefix":"10.7759","author":[{"given":"Ruochen","family":"Ying","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmol","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Hajifathalian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cancer stat facts. pancreatic cancer. (2023). Accessed: April 9, 2023: https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html."},{"key":"ref2","unstructured":"Cancer stat facts. liver and intrahepatic bile duct cancer. (2023). Accessed: April 9, 2023: https:\/\/seer.cancer.gov\/statfacts\/html\/livibd.html."},{"key":"ref3","unstructured":"Compare cancer sites SEER 5-year age-adjusted incidence rates, 2015-2019. (2023). Accessed. April 9, 2023: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=9999&data_type=1&graph_type=10&compareBy=si...."},{"key":"ref4","unstructured":"Pancreatic cancer. stages. (2022). Accessed: April 9, 2023: https:\/\/www.cancer.net\/cancer-types\/pancreatic-cancer\/stages#:~:text=Metastatic,are%20diagnosed%20with%20this%20stage."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.459","article-title":"Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer","volume":"4","author":"Peixoto RD","year":"2015","unstructured":"Peixoto RD, Speers C, McGahan CE, Renouf DJ, Schaeffer DF, Kennecke HF. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. Cancer Med. 2015, 4:1171-7. 10.1002\/cam4.459","journal-title":"Cancer Med"},{"key":"ref6","article-title":"Biliary Tract Cancer","author":"Zamani Z","year":"2023","unstructured":"Zamani Z, Fatima S. Biliary Tract Cancer. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1772","article-title":"Pattern of distant metastases in primary extrahepatic bile-duct cancer: a SEER-based study","volume":"7","author":"Wang X","year":"2018","unstructured":"Wang X, Yu GY, Chen M, Wei R, Chen J, Wang Z. Pattern of distant metastases in primary extrahepatic bile-duct cancer: a SEER-based study. Cancer Med. 2018, 7:5006-14. 10.1002\/cam4.1772","journal-title":"Cancer Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2017.11.006","article-title":"Bone metastases in biliary cancers: a multicenter retrospective survey","volume":"12","author":"Santini D","year":"2018","unstructured":"Santini D, Brandi G, Aprile G, et al.. Bone metastases in biliary cancers: a multicenter retrospective survey. J Bone Oncol. 2018, 12:33-7. 10.1016\/j.jbo.2017.11.006","journal-title":"J Bone Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.08.16","article-title":"Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study","volume":"8","author":"Zheng XQ","year":"2019","unstructured":"Zheng XQ, Huang JF, Lin JL, et al.. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. Transl Lung Cancer Res. 2019, 8:367-79. 10.21037\/tlcr.2019.08.16","journal-title":"Transl Lung Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v5.i2.149","article-title":"Bone metastases: when and how lung cancer interacts with bone","volume":"5","author":"Roato I","year":"2014","unstructured":"Roato I. Bone metastases: when and how lung cancer interacts with bone. World J Clin Oncol. 2014, 5:149-55. 10.5306\/wjco.v5.i2.149","journal-title":"World J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-020-00390-3","article-title":"Cholangiocarcinoma: state of the art","volume":"51","author":"Moazzami B","year":"2020","unstructured":"Moazzami B, Majidzadeh-A K, Dooghaie-Moghadam A, et al.. Cholangiocarcinoma: state of the art. J Gastrointest Cancer. 2020, 51:774-81. 10.1007\/s12029-020-00390-3","journal-title":"J Gastrointest Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2018.07.02","article-title":"Precision medicine in cholangiocarcinoma","volume":"3","author":"Pellino A","year":"2018","unstructured":"Pellino A, Loupakis F, Cadamuro M, et al.. Precision medicine in cholangiocarcinoma. Transl Gastroenterol Hepatol. 2018, 3:40. 10.21037\/tgh.2018.07.02","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1157","article-title":"Multiomic analysis reveals comprehensive tumor heterogeneity and distinct immune subtypes in multifocal intrahepatic cholangiocarcinoma","volume":"28","author":"Chen S","year":"2022","unstructured":"Chen S, Xie Y, Cai Y, et al.. Multiomic analysis reveals comprehensive tumor heterogeneity and distinct immune subtypes in multifocal intrahepatic cholangiocarcinoma. Clin Cancer Res. 2022, 28:1896-910. 10.1158\/1078-0432.CCR-21-1157","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31862","article-title":"Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1\/programmed death-ligand 1 blockade responses","volume":"74","author":"Yoon JG","year":"2021","unstructured":"Yoon JG, Kim MH, Jang M, et al.. Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1\/programmed death-ligand 1 blockade responses. Hepatology. 2021, 74:1914-31. 10.1002\/hep.31862","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i14.1732","article-title":"Diagnostic-therapeutic management of bile duct cancer","volume":"7","author":"Huguet JM","year":"2019","unstructured":"Huguet JM, Lobo M, Labrador JM, et al.. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases. 2019, 7:1732-52. 10.12998\/wjcc.v7.i14.1732","journal-title":"World J Clin Cases"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle J","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al.. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010, 362:1273-81. 10.1056\/NEJMoa0908721","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/151246-rare-manifestation-of-pancreaticobiliary-cancer-with-extrahepatic-lesions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:16Z","timestamp":1707508936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/151246-rare-manifestation-of-pancreaticobiliary-cancer-with-extrahepatic-lesions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.43276","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}